A week af­ter dis­clos­ing lay­offs, Bridge­Bio nets a $90M up­front can­cer R&D pact with Bris­tol My­ers

Bridge­Bio has lo­cat­ed the bridge to green­er pas­tures, specif­i­cal­ly the lav­ish pur­ple of Bris­tol My­ers Squibb.

The two are col­lab­o­rat­ing in a deal giv­ing the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER